Tech Company Financing Transactions

Chimerix Funding Round

Chimerix, operating out of Durham, secured $11 million from Frazier Healthcare Partners, Asset Management Ventures and Sanderling Ventures.

Transaction Overview

Company Name
Chimerix
Announced On
11/4/2004
Transaction Type
Venture Equity
Amount
$11,000,000
Round
Series C
Investors

Frazier Healthcare Partners (Lead Investor) (Robert Overell)

Asset Management Ventures (Graham Crooke)

Sanderling Ventures

Proceeds Purpose
This financing provides resources for the company to advance our current therapeutic programs and to broaden the application of our proprietary technology to new commercially attractive therapeutic indications.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2505 Meridian Pkwy. 100
Durham, NC 27713
USA
Phone
(919) 806-1074
Website
www.chimerix.com
Email Address
[email protected]
Overview
Incorporated in 2000, Chimerix is a biopharmaceutical company committed to the discovery, development, and commercialization of novel oral antiviral therapeutics that are designed to transform patient care in areas of high unmet medical need.
Profile
Chimerix LinkedIn Company Profile
Social Media
Chimerix Company Twitter Account
Company News
Chimerix News
Facebook
Chimerix on Facebook
YouTube
Chimerix on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Michael Sherman
  Michael Sherman LinkedIn Profile  Michael Sherman Twitter Account  Michael Sherman News  Michael Sherman on Facebook
Chief Medical Officer
Garrett Nichols
  Garrett Nichols LinkedIn Profile  Garrett Nichols Twitter Account  Garrett Nichols News  Garrett Nichols on Facebook
Chief Scientific Officer
Randall Lanier
  Randall Lanier LinkedIn Profile  Randall Lanier Twitter Account  Randall Lanier News  Randall Lanier on Facebook
VP - Client Services
Odin Naderer
  Odin Naderer LinkedIn Profile  Odin Naderer Twitter Account  Odin Naderer News  Odin Naderer on Facebook
VP - General Counsel
Michael Alrutz
  Michael Alrutz LinkedIn Profile  Michael Alrutz Twitter Account  Michael Alrutz News  Michael Alrutz on Facebook
VP - Manufacturing
Roy Ware
  Roy Ware LinkedIn Profile  Roy Ware Twitter Account  Roy Ware News  Roy Ware on Facebook

 

 

Browse more venture capital transactions:

Prev: 11/3/2004: Platform Solutions venture capital transaction
Next: 11/4/2004: Relievant Medsystems venture capital transaction

 

Share this article

 

About Our VC Transactions Data

Our team works diligently to report on every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.